Reversal of synaptic impairments in a rTg4510 transgenic AD mouse model was obtained with compound NVP-HSP990 which has a high Hsp70 induction capacity and is probably able to induce Tau clearance [135]. The gene discussed is MAPT; the disease is Alzheimer disease.